Related Experiment Videos
Effect of polyprenoic acid (E5166) on a human neuroblastoma cell line in culture
Abstract:
The antineoplastic effects of a novel retinoid derivative E5166 on cultured human neuroblastoma, GOTO cells, were investigated. E5166, as well as retinoic acid and retinol, suppressed the proliferation of GOTO cells and the synthesis of DNA, RNA and protein; the inhibitory potency of E5166 was not stronger than that of the natural vitamin A derivatives. E5166 also inhibited amino acid transport, but was found to stimulate sugar transport in the neuroblastoma cells.
Insights
Novel retinoid derivative E5166 showed antineoplastic effects on human neuroblastoma cells, suppressing proliferation and macromolecule synthesis. E5166 also impacted amino acid and sugar transport in these cancer cells.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Neuroblastoma is a pediatric cancer with limited treatment options.
- Retinoids, vitamin A derivatives, have shown potential in cancer therapy.
- Novel retinoid derivatives are being explored for enhanced antineoplastic activity.
Purpose of the Study:
- To investigate the antineoplastic effects of a novel retinoid derivative, E5166.
- To compare the efficacy of E5166 with natural vitamin A derivatives (retinoic acid, retinol).
- To examine the impact of E5166 on cellular transport mechanisms in neuroblastoma cells.
Main Methods:
- Cultured human neuroblastoma GOTO cells were used for in vitro studies.
- Cell proliferation and macromolecule synthesis (DNA, RNA, protein) were measured.
- Amino acid and sugar transport assays were performed.
Main Results:
- E5166 suppressed proliferation and macromolecule synthesis in GOTO cells.
- The inhibitory potency of E5166 was comparable to retinoic acid and retinol.
- E5166 inhibited amino acid transport but stimulated sugar transport in neuroblastoma cells.
Conclusions:
- E5166 exhibits antineoplastic properties against human neuroblastoma cells.
- E5166's effects on cellular transport may contribute to its mechanism of action.
- Further research into E5166 as a potential neuroblastoma therapeutic is warranted.